Chlamydia

Sexually Transmitted Diseases

Volumn , Issue , 2013, Pages 369-410

  Hafner, Louise M ^a   Timms, Peter ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882884122     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391059-2.00015-2     Document Type: Chapter

References (217)

1. AbdelRahman Y.M., Belland R.J. The chlamydial developmental cycle. FEMS Microbiology Reviews 2005, 29:949-959.
2. Abdul-Sater A.A., Saïd-Sadier N., Padilla E.V., et al. Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome. Microbes Infect. 2010, 12(8-9):652-661.
3. Agrawal T., Vats V., Sudha Salhan S., et al. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women. J. Reprod. Immunol. 2009, 83(1-2):173-178.
4. Andrew D.W., Hafner L.M., Beagley K.W., Timms P. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model. J. Reprod. Immunol. 2011, 91:9-16.
5. Asquith K.L., Horvat J.C., Kaiko G.E., et al. Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog. 2011, 7(5):e1001339.
6. Bachmann L.H., Johnson R.E., Cheng H., et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J. Clin. Microbiol. 2010, 48(5):1827-1832.
7. Bandea C.I., Kubotaa K., Brown T.M., et al. Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein (Omp1). Sex. Transm. Infect. 2001, 77:419-422.
8. Beagley K.W., Huston W.M., Hansbro P.M., et al. Chlamydial infection of immune cells: altered function and implications for disease. Crit. Rev. Immunol. 2009, 29(4):275-305.
9. Beatty W.L., Byrne G.I., Morrison R.P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends in Microbiol. 1994, 2(3):94-98.
10. Beem M.O., Saxon E.M. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N. Engl. J. Med. 1977, 296(6):306-310.
11. Bell T.A., Stamm W.E., Wang S.P., et al. Chronic Chlamydia trachomatis infections in infants. Journal of the American Medical Association 1992, 267(3):400-402.
12. Bell J.D., Bergin I.L., Schmidt K., et al. Nonhuman primate models used to study pelvic inflammatory disease caused by Chlamydia trachomatis. Infect. Dis. Obstet. Gynecol. 2011, 2011(675360):7. doi:10.1155/2011/675360:675360.
13. Betts-Hampikian H.J., Fields K.A. The Chlamydial Type III Secretion Mechanism: revealing Cracks in a Tough Nut. Front Microbiol. 2010, 114:1-13.
14. Betts H.J., Wolf K., Fields K.A. Effector protein modulation of host cells: examples in the Chlamydia spp. Arsenal. Curr. Opin. Microbiol. 2009, 12:81-87.
15. Bowman R.J., Jatta B., Cham B. Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up. Ophthalmology 2001, 108:2163-2164.
16. Bradshaw C.S., Tabrizi S.N., Read T.R., et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J. Infect. Dis. 2006, 193:336-345.
17. Braun J., Laitko S., Treharne J., et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann. Rheum. Dis. 1994, 2(53):100-105.
18. Brill J.R. Diagnosis and treatment of urethritis in men. Amer. Fam. Physician 2010, 81(7):873-878.
19. Broadbent A., Horner P., Wills G., et al. HIV-1 does not significantly influence Chlamydia trachomatis serovar L2 replication in vitro. Microbes and Infect. 2011, 13:575-584.
20. Brocklehurst P., Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy. Cochrane Database Syst. Rev. 2000, (2):CD000054.
21. Brunham R., Paavonen J., Stevens C.E., et al. Mucopurulent cervicitis - the ignored counterpart in women of urethritis in men. New Eng. J. Med. 1984, 311:1-6.
22. Brunham R.C., Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 2005, 5:149-161.
23. Bucholz K.R., Stephens R.S. Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis. Cell. Microbiol. 2006, 8:1768-1779.
24. Burall, L.S., Rodolakis A, Rekiki A, et al., (2009). Genomic analysis of an attenuated Chlamydia abortus live vaccine strain reveals defects in central metabolism and surface proteins. 77(9):4161-4167.
25. Burton M.J., Bailey R.L., Jeffries D., et al. Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect. Immun. 2004, 72:7352-7356.
26. Burton M.J. Trachoma: an overview. Br. Med. Bull. 2007, 84:99-116.
27. Bush R.M., Everett K.D. Molecular evolution of Chlamydiaceae. Int. J. Syst. Evol. Microbiol. 2001, 51:203-220.
28. Byrne G.I. Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J. Infect. Dis. 2010, 201(Suppl. 2):S126-S133.
29. Caldwell H.D., Kuo C.C., Kenny G.E. Antigenic analysis of Chlamydiae by two- dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen. J. Immunol. 1975, 115:969-975.
30. Caldwell H.D., Wood H., Crane D., et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 2003, 111:1757-1769.
31. Carlson J.H., Hughes S., Hogan D., et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. Immun. 2004, 72(12):7063-7072.
32. Carlson J.H., Porcella S.F., McClarty G., et al. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect. Immun. 2005, 73(10):6407-6418.
33. Carter J.D., Gérard H.C., Espinoza L.R., et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009, 60(5):1311-1316.
34. Carter J.D., Hudson A.P. The evolving story of Chlamydia-induced reactive arthritis. Curr.Opin. Rheumatol. 2010, 22(4):424-430.
35. Carter J.D., Inman R.D., Whittum-Hudson J., et al. Chlamydia and chronic arthritis. Annals of Medicine, Early Online 2011, 1-9. Aug 24. [Epub ahead of print].
36. Centers for Disease Control and Prevention A cluster of lymphogranuloma venereum among men who have sex with men-Netherlands, 2003-2004. MMWR Morb. Mortal. Wkly. Rep 2004, 53:985-988.
37. Centers for Disease Control and Prevention Sexually Transmitted Disease Surveillance, 2008 2009, US Department of Health and Human Services, Atlanta, GA.
38. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2010: diseases characterised by urethritis and cervicitis 2010, Accessed 12 October, 2011. http://www.cdc.gov/std/treatment/2010/STD-Treatment-2010-RR5912.pdf.
39. Centers for Disease Control and Prevention Sexually Transmitted Disease Surveillance 2009, Division of STD prevention, November 2010 2011, Accessed October 10, 2011. http://www.cdc.gov/std/stats09/chlamydia.htm.
40. Chandran L., Boykan R. Chlamydial infections in children and adolescents. Pediatr. Rev. 2009, 30(7):243-250.
41. Cheng C., Pal S., Bettahi I., et al. Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine 2011, 29:3456-3464.
42. Cheng W., Shivshankar P., Zhong Y., et al. Intracellular interleukin-1 alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect. Immun. 2008, 76(3):942-951.
43. Chesson H., Blandford J., Gigt.T., et al. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect. Sexual Reprod. Health 2004, 36:11-19.
44. Chesson H.W., Gift T.L., Owusu-Edusei K., et al. A Brief Review of the Estimated Economic Burden of Sexually Transmitted Diseases in the United States. Inflation-Adjusted Updates of Previously Published Cost Studies. Sex. Transm. Dis. 2011, 38(10):889-891.
45. Cocchiaro J.L., Valdivia R.H. New insights into Chlamydia intracellular survival mechanisms. Cell. Microbiol. 2009, 11(11):1571-1578.
46. Courtright P., West S.K. Contribution of sex-linked biology and gender roles to disparity with trachoma. Emerg. Infect. Dis. 2004, 10:2012-2016.
47. Cunningham K.A., Beagley K.W. Male Genital Tract Chlamydial Infection: Implications for Pathology and Infertility. Biology of Reproduction 2008, 79:180-189.
48. Darville T., O'Neill J.M., Andrews C.W., et al. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 1 2003, 171(11):6187-6197.
49. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin. Pediatr. Infect. Dis. 2005, 16(4):235-244.
50. Dean D., Suchland R.J., Stamm W.E. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. JID 2000, 182:909-916.
51. Dean D., Powers V.C. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Infection and Immunity 2001, 69(4):2442-2447.
52. Dean D., Miller K. Molecular and mutation trend analysis of omp1 alleles for serovar E of Chlamydia trachomatis: implications for the immunopathogenesis of disease. J. Clin. Invest. 1997, 99:475e83.
53. Debattista J., Timms P., Allan J., et al. Immunopathogenesis of Chlamydia trachomatis infections in women. Fertil. Steril. 2003, 79(6):1273-1287.
54. De Jong Z., Pontonnier F., Plante P., et al. The frequency of Chlamydia trachomatis in acute epididymitis. Br. J. Urol. 1988, 62:76-78.
55. De Munain J.L., Ezpeleta G., Imaz M., Del Mar Camara M., Esteban V., Santamaría J.M., Cisterna R. Two lymphogranuloma venereum cases in a heterosexual couple in Bilbao (Spain). Sex. Transm. Dis. 2008, 35(11):918-919.
56. Dong-Ji Z., Yang X., Shen C., et al. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect. Immun. 2000, 68:3074-3078.
57. Dunn J.D., Valdivia R.H. Uncivil engineers: Chlamydia, Salmonella and Shigella alter cytoskeleton architecture to invade epithelial cells. Future Micro. 2010, 5(8):1219-1232.
58. Eckert L.O., Hawes S.E., Wölner-Hanssen P.K., et al. Endometritis: the clinical pathologic syndrome. Am. J. Obstet. Gynecol. 2002, 186(4):690-695.
59. Elwell C.A., Jiang S., Kim J.H., et al. Chlamydia trachomatis Co-opts GBF1 and CERT to Acquire Host Sphingomyelin for Distinct Roles during Intracellular Development. PLoS Pathog. 2011, 7(9):e1002198.
60. Evans J.R., Solomon A.W. Antibiotics for trachoma. Cochrane Database Syst. Rev. 2011, 3:CD001860.
61. Falk L. The overall agreement of proposed definitions of mucopurulent cervicitis in women at high risk of chlamydial infection. Acta. Derm. Venereol. 2010, 90:506-511.
62. Falk L., Fredlund H., Jensen J.S. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex. Trans. Infect. 2005, 81:73-78.
63. Farencena A., Comanducci M., Donati M., et al. Characterization of a new isolate of Chlamydia trachomatis which lacks the common plasmid and has properties of biovar trachoma.Infect. Immun. 1997, 65:2965-2969.
64. Feghali J., Bakar J., Mayenga J.M., et al. Systematic hysteroscopy prior to in vitro fertilization. Gynecol. Obstet. Fertil. 2003, 31:127-131.
65. Ferreira V.H., Nazli A., Khan G., et al. Endometrial epithelial cell responses to coinfecting viral and bacterial pathogens in the genital tract can activate the HIV-1 LTR in an NF{kappa}B-and AP1-dependent manner. J. Infect. Dis. 2011, 204(2):299-308.
66. Fontenot J.D., Rasmussen J.P., Williams L.M., et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22(3):329-341.
67. Fung M., Scott K.C., Kent C.K., et al. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex. Transm. Infect. 2007, 83:304-309.
68. Gall A., Horowitz A., Joof H., et al. Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis. Frontiers in Microbiology 2011, 2(10):1-13.
69. Gambir M., Basanez M., Turner F., et al. Trachoma: transmission, infection and control. Lancet Infect. Dis. 2007, 7:420-427.
70. Geisler W.M. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. Infect. Dis. 2010, 201(Suppl. 2):S104-S113.
71. Gérard H.C., Whittum-Hudson J.A., Carter J.D., et al. The pathogenic role of Chlamydia in spondyloarthritis. Curr. Opin. Rheumatol. 2010, 22(4):363-367.
72. Gomes J., Nunes A., Florindo C., Ferreira M., et al. Lymphogranuloma venereum in Portugal: unusual events and new variants during 2007. Sex Transm. Dis. 2009, 36(2):88-91.
73. Gray R.T., Beagley K., Timms P., et al. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J. Infect. Dis. 2009, 199:1680-1688.
74. Grayston J.T., Woolridge R., Wang S. Trachoma vaccine studies on Taiwan. Ann. NY Acad. Sci. 1962, 98:352-367.
75. Hafner L.M., Beagley K.W., Timms P. Chlamydia trachomatis infection: host immune responses and potential vaccines. Mucosal Immunology 2008, 1(2):116-130.
76. Hafner L.M., McNeilly C. Vaccines for Chlamydia infections of the female genital tract. Future Microbiology 2008, 3(1):67-77.
77. Hafner L.M., Pelzer E.S. Tubal Damage, Infertility and Tubal Ectopic Pregnancy: Chlamydia trachomatis and Other Microbial Aetiologies. Ectopic Pregnancy - Modern Diagnosis and Management 2011, Michael Kamrava Publisher, InTech, ISBN 978-953-307-648-5.
78. Haggerty C.L., Ness R.B., Amortegui A., et al. Endometritus does not predict reproductive morbidity after pelvic inflammatory disease. Am. J. Obstet. Gynecol. 2003, 188(1):141-148.
79. Haggerty C.L., Gottlieb S.L., Taylor B.D., et al. Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women. J. Infect. Dis. 2010, 201(Suppl. 2):S134-S135.
80. Hammerschlag M.R. The intracellular life of chlamydiae. Semin. Pediatr. Infect. Dis. 2002, 13(4):239-248.
81. Hansen J., Jensen K.T., Follmann F., et al. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model. J. Infect. Dis. 2008, 198:758-767.
82. Hannu T., Puolakkainen M., Leirisalo-Repo M. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) 1999, 38(5):411-414.
83. Harkins A.L., Munson E. Molecular Diagnosis of Sexually Transmitted Chlamydia Trachomatis in the United States. ISRN Obstet. Gynecol. 2011, 2011:279149.
84. He Q., Martinez-Sobrido L., Eko F., et al. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology 2007, 122(1):28-37.
85. Hickey D.K., Patel M.V., Fahey J.V., et al. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J. Reprod. Immunol. 2011, 88(2):185-194.
86. Hjelholt A., Christiansen G., Johannesson T.G., et al. Tubal factor infertility is associated with antibodies against Chlamydia trachomatis heat shock protein 60 (HSP60) but not human HSP60. Hum. Reprod. 2011, 26(8):2069-2076.
87. Hogan R.J., Mathews S.A., Kutlin A., et al. Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microb. Pathog. 2003, 34(1):11-16.
88. Hori S., Tsutsumi Y. Histological differentiation between chlamydial and bacterial epididymitis: nondestructive and proliferative versus destructive and abscess forming -immunohistochemical and clinicopathological findings. Hum. Pathol. 1995, 26(4):402-447.
89. Huston W.M., Tyndall J.D., Lott W.B., et al. Unique Residues Involved in Activation of the Multitasking Protease/Chaperone HtrA from Chlamydia trachomatis. PLoS One 2011, 6(9):e24547.
90. Hvid M., Baczynska A., Deleuran B., Fedder J., et al. Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell. Microbiol. 2007, 9(12):2795-2803.
91. Hybiske K., Stephens R.S. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. PNAS 2007, 104(27):11430-11435.
92. Institute of Medicine (US) Committee to Study Priorities for Vaccine Development Vaccines for the 21st Century 2000, National Academy Press, Washington, DC.
93. Johansson M., Schon K., Ward M., et al. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in γ interferon receptor deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 1997, 73:1032-1044.
94. Johansson M., Lycke N. Immunological memory in B-cell-deficient mice conveys long lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells. Immunology 2001, 102(2):199-208.
95. Jorgensen I., Bednar M.M., Amin V., et al. The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence. Cell. Host. Microbe 2011, 10(1):21-32.
96. Johnson R.E., Green T.A., Schacter J., et al. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J. Clin. Microbiol. 2000, 38:4382-4386.
97. Johnson R.M. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect. Immun. 2004, 72:3951-3960.
98. Kalman S., Mitchell W., Marathe R., et al. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 1999, 21(4):385-389.
99. Karam G., Martin D., Flotte T., et al. Asymptomatic Chlamydia trachomatis infections among sexually active men. J. Infect. Dis. 1986, 154(5):900-903.
100. Kari L., Whitmire W.M., Carlson J.H., et al. Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations. J. Infect. Dis. 2008, 197(3):449-456.
101. Kari L., Whitmire W.M., Crane D.D., et al. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J. Immunol. 2009, 182:8063-8070.
102. Kari L., Goheen M.M., Randall L.B., et al. Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl. Acad. Sci. U S A. 2011, 108(17):7189-7193.
103. Kari L., Whitmire W.M., Olivares-Zavaleta N., et al. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. Journal of Experimental Medicine 2011, 208(11):1-7.
104. Karunakaran K.P., Rey-Ladino J., Stoynov N., et al. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J. Immunol. 2008, 180(4):2459-2465.
105. Kaushic C., Zhou F., Murdin A.D., et al. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 2000, 68(7):4207-4216.
106. Kelly K.A. Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms. Int. Rev. Immunol. 2003, 22(1):3-41.
107. Kim J.H., Jiang S., Elwell C.A., et al. Chlamydia trachomatis Co-opts the FGF2 Signaling Pathway to Enhance Infection. PLoS Pathog 2011, 7(10):e1002285. Epub 2011 Oct 6.
108. Kissinger P.J., Reilly K., Taylor S.N., et al. Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. Sex. Transm. Dis. 2009, 36:498-500.
109. Longbottom D., Russell M., Jones G.E., et al. Identification of a multigene family coding for the 90 kDa proteins of the ovine abortion subtype of Chlamydia psittaci. FEMS Microbiol. Lett. 1996, 142(2-3):277-281.
110. Lusk M.J., Konecny P. Cervicitis: a review. Curr. Opin. Infect. Dis. 2008, 21:49-55.
111. Mabey D., Peeling R.W. Lymphogranuloma venereum. Sex. Transm. Infect. 2002, 78:90-92.
112. Mackern-Oberti J.P., Motrich R.D., Breser M.L., et al. Male rodent genital tract infection with Chlamydia muridarum: persistence in the prostate gland that triggers self immune reactions in genetically-susceptible hosts. J. Urol. 2011, 186(3):1100-1106.
113. Macmillan L., Ifere G.O., He Q. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. FEMS Immunol. Med. Micro. 2007, 49(1):46-55.
114. Madeleine M., Anttila T., Schwartz S., et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int. J. Cancer 2007, 120(3):650-655.
115. Manavi K., Turner K., Scott G.R., et al. Audit on the management of epididymo-orchitis by the Department of Urology in Edinburgh. Int. J. STD AIDS 2005, 16(5):386-387.
116. Marks E., Tam M.A., Lycke N.Y. The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection. PLoS Pathog. 4 2010, 6(11):e1001179.
117. Marrazzo J.M., Martin D.H. Management of women with cervicitis. Clin. Infect. Dis. 2007, 44(Suppl. 3):S102-S110.
118. Marcus J.L., Kohn R.P., Barry P.M., et al. Chlamydia trachomatis and Neisseria gonorrhoeae Transmission from the Female Oropharynx to the Male Urethra. Sex. Transm. Dis. 2011, 38(5):372-373.
119. Mariotti S.P., Pascolini D., Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br. J. Ophthalmol. 2009, 93(5):563-568.
120. Martin-Iguacel R., Llibre J.M., Nielsen H., et al. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29(8):917-925.
121. Matsumoto A. Structural characteristics of chlamydial bodies. Microbiology of Chlamydia 1988, 21-45. CRC Press, Inc., Boca Raton, Florida. A.L. Barron (Ed.).
122. Melekos M.D., Asbach H.W. The role of chlamydiae in epididymitis. Int. Urol. Nephrol. 1988, 20(3):293-297.
123. Mestecky J., Moldoveanu Z., Russell M. Immunologic uniqueness of the genital tract: challenge for vaccine development. American Journal of Reproductive Immunology 2005, 53:208-214.
124. Mital J., Hackstadt T. Diverse requirements for SRC-family tyrosine kinases distinguish chlamydial species. MBio. 2011, 2(2). pii: e00031-11. doi:10.1128/mBio.00031-11.
125. Mittal A., Rastogi S., Reddy B.S., et al. Enhanced immunocompetent cells in chlamydial cervicitis. J. Reprod. Med. 2004, 49(8):671-677.
126. Mitchell C.M. Morphologic and genomic characterisation of the koala Chlamydia pneumoniae strain. PhD Thesis. Institute of Health and Biomedical Innovation (IHBI) 2010, Queensland University of Technology(QUT) Brisbane, Australia.
127. Moniz R.J., Chan A.M., Kelly K.A. Identification of dendritic cell subsets responding to genital infection by Chlamydia muridarum. FEMS Immunol. Med. Microbiol. 2009, 55(2):226.
128. Moniz R.J., Chan A.M., Gordon L.K., et al. Plasmacytoid denritic cells modulate nonprotective T-cell responses to genital infection by Chlamydia muridarum. FEMS Immunol. Med. Microbiol. 2010, 58(3):397-404.
129. Morre S.A., Ossewaarde J.M., Lan J., et al. Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J. Clin. Microbiol. 1998, 36(2):345-351.
130. Morrison S.G., Morrison R.P. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 2005, 175:7536-7542.
131. Motrich R.D., Cuffini C., Oberti J.P., et al. Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients. J. Infect. 2006, 53(3):175-183.
132. MMWR Morb.Mortal.Wkly Rep. Apr 1;60(12):370-3.CDC Grand Rounds:Chlamydia prevention:challenges and strategies for reducing disease burden and sequelae 2011, Centers for Disease Control and Prevention (CDC), Atlanta, GA.
133. Mulcahy F.M., Bignell C.J., Rajakumar R., et al. Prevalence of chlamydial infection in acute epididymo-orchitis. Genitourin. Med. 1987, 63(1):16-18.
134. Murphey C., Murthy A.K., Meier P.A., et al. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell. Immunol. 2006, 242:110-117.
135. Murthy A.K., Li W., Chaganty B.K., et al. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 2011, 79:2928-2935.
136. Myers G.S., Mathews S.A., Eppinger M., et al. Evidence that human Chlamydia pneumoniae was zoonotically acquired. J. Bacteriol. 2009, 191(23):7225-7233.
137. Nguyen B.D., Cunningham D., Liang X., et al. Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis. Proc. Natl. Acad. Sci. U S A. 2011, 108(25):10284-10289.
138. Nieuwenhuis R.F., Ossewaarde J.M., Götz H.M., et al. Resurgence of lymphogranuloma venereum in WesternEurope: an outbreak of Chlamydia trachomatis serovar l2 proctitis in the Netherlands among men who have sex with men. Clin. Infect. Dis. 2004, 39(7):996-1003.
139. Nicholson A., Rait G., Murray-Thomas T. Management of epididymo-orchitis in primary care: results from a large UK primary care database. Br. J. Gen. Pract. 2010, 60(579):e407-e422.
140. O'Connell C.M., Ingalls R.R., Andrews C.W., et al. Plasmid deficient Chlamydia muridarum fails to induce immune pathology and protect against oviduct disease. J. Immunol. 2007, 179:4027-4034.
141. O'Connell C.M., AbdelRahman Y.M., Green E., et al. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect. Immun. 2011, 79(3):1044-1056.
142. Ochiel D.O., Fahey J.V., Ghosh M., et al. Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens. Curr. Womens Health Rev. 2008, 4(2):102-117.
143. Ouzounova-Raykova V., Ouzounova I., Mitov I.G. May Chlamydia trachomatis be an aetiological agent of chronic prostatic infection?. Andrologia 2010, 42(3):176-181.
144. Pai S.Y., Truitt M.L., Ho I.C. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. U S A. 2004, 101(7):1993-1998.
145. Pal S., Peterson E.M., Rappuoli R., et al. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine 2006, 24:766-775.
146. Peterson E.M., Markoff B.A., Schachter J., et al. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid. 1990, 23:144-148.
147. Peuchant O., Baldit C., Le Roy C., et al. First case of Chlamydia trachomatis L2b proctitis in a woman. Clin. Micro. Infect. 2011, Aug 28. doi: 10.1111/j.1469-0691.2011.03661.x.
148. Ramsey K.H., Sigar I.M., Schripsema J.H., et al. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect. Immun. 2009, 77(8):3284-3393.
149. Rasmussen S.J., Eckmann L., Quayle A.J., et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 1997, 99(1):77-87.
150. Read T.D., Brunham R.C., Shen C., et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic. Acids Res. 2000 2000, 28(6):1397-1406.
151. Read T.D., Myers G.S., Brunham R.C., et al. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic. Acids Res. 2003, 31(8):2134-2247.
152. Redfern T.R., English P.J., Baumber C.D., et al. The aetiology and management of acute epididymitis. Br. J. Surg. 1984, 71(9):703-705.
153. Resnikoff S., Pascolini D., Etya'ale D., Kocur, et al. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization 2004, 82(11):844-851.
154. Rey-Ladino J., Jiang X., Gabel B.R., et al. Survival of Chlamydia muridarum within dendritic cells. Infect. Immun. 2007, 75(8):3707-3714.
155. Rey-Ladino J., Koochesfahani K.M., Zaharik M.L. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct. Infect. Immun. 2005, 73(3):1568-1577.
156. Roan N.R., Starnbach M.N. Immune-mediated control of Chlamydia infection. Cellular Microbiology 2008, 10(1):9-19.
157. Robertson T., Bibby S., O'Rourke D., et al. Characterization of Chlamydiaceae species using PCR and high resolution melt curve analysis of the 16S rRNA gene. J. Appl. Microbiol. 2009, 107(6):2017-2028.
158. Ripa T., Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Eur. Surveill. 2006, 11:E061109.
159. Rockey D.D. Unravelling the basic biology and clinical significance of the chlamydial plasmid. J. Exp. Med. 2011, 208(11):2159-2162.
160. Rodgers A.K., Wang J., Zhang Y., et al. Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am. J. Obstet. Gynecol. 2010, 203(5):494.e7-494.e14.
161. Rosenman M.B., Mahon B.E., Downs S.M., et al. Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis. Arch. Pediatr. Adolesc. Med. 2003, 157(6):565-571.
162. Rottenberg M.E., Gigliotti-Rothfuchs A., Wigzell H. The role of IFN-gamma in the outcome of chlamydial infection. Curr. Opin. Immunol. 2002, 14(4):444-451. Review.
163. Saka H.A., Valdivia R.H. Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment. Curr. Opin. Microbiol. 2010, 13(1):4-10.
164. Sanchez-Campillo M., Bini L., Comanducci M., et al. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 1999, 20(11):2269-2279.
165. Scidmore M.A. Recent advances in Chlamydia subversion of host cytoskeletal and membrane trafficking pathways. Microbes & Infect. 2011, 13:527-535.
166. Schachter J., Grossman M., Sweet R.L., et al. Prospective Study of Perinatal Transmission of Chlamydia trachomatis. JAMA 1986, 255(24):3374-3377.
167. Schachter J., Stephens R.S., Timms P., et al. Radical changes to chlamydial taxonomy are not necessary just yet. Int. J. Syst. Evol. Microbiol. 2001, 51:251-253.
168. Schachter J., Stephens R.S. Biology of Chlamydia trachomatis. Sexually Transmitted Diseases 2008, 555-574. The McGraw-Hill Companies. fourth ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey, M.S. Cohen, C. Watts (Eds.).
169. Shirai M., Hirakawa H., Kimoto.M., et al. Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res. 15 2000, 28(12):2311-2314.
170. Schoborg R.V. Chlamydia persistence - a tool to dissect chlamydia-host interactions. Microb. and Infect. 2011, 13:649-662.
171. Scurlock A.M., Frazer L.C., Andrews C.W., et al. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect. Immun. 2011, 79(3):1349-1362.
172. Shahmanesh M., Moi H., Lassau F., et al. 2009 European guideline on the management of male Non-gonococcal Urethritis. Int. J. STD & AIDS 2009, 20:458-464.
173. Shaw J.L., Wills G.S., Lee K.F., et al. Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancy. Am. J. Pathol. 2011, 178(1):253-260.
174. Singh D., Fine D., Marrazzo J.M. Chlamydia trachomatis infection among women reporting sexual activity with women screened in family planning clinics in the Pacific Northwest, 1997 to 2005. Am. J. Public Health 2011, 101(7):1284-1290.
175. Somboonna N., Wan R., Ojcius D.M., et al. Hypervirulent clinical strain is a recombinant between lymphogranuloma venereum L(2) and D lineages. MBio. 2011, 2(3). e00045-11.
176. Sonnex C. Toll like receptors and genital tract infection. Int. J. STD & AIDS 2009, 21:153-157.
177. Stamm W.E. Lymphogranuloma venereum. Sexually Transmitted Diseases 2008, 595-605. The McGraw-Hill Companies, New York. K.K. Holmes, P.F. Sparling, P.-A. Mardh (Eds.).
178. Stamm W.E. Chlamydia trachomatis infections in the adult. Sexually Transmitted Diseases 2008, The McGraw-Hill Companies, New York. K.K. Holmes, P.F. Sparling, P.-A. Mardh (Eds.).
179. Starnbach M.N., Loomis W.P., Ovendale P., et al. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J. Immunol. 2003, 171(9):4742-4749.
180. Stary G., Meyer T., Bangert C., et al. New Chlamydia trachomatis L2 strains identified in a recent outbreak of lymphogranuloma venereum in
181. Stemke-Hale K., Kaltenboeck B., Degraves F., et al. Screening the whole genome of a pathogen in vivo for individual protective antigens. Vaccine 2005, 23(23):3016-3025.
182. Stephens R.S., Wagar E.A., Schoolnik G.K. High-resolution mapping of serovar specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 1988, 167:817-831.
183. Stephens R.S., Sanchez-Pescador R., Wager E., et al. Diversity of the major outer membrane proteins of Chlamydia trachomatis. J. Bacteriol. 1987, 169:3879-3885.
184. Stephens R.S., Kalman S., Lammel C., et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998, 282(5389):754-779.
185. Stephens R.S., Myers G., Eppinger M., et al. Divergence without difference: phylogenetics and taxonomy of Chlamydia resolved. FEMS immunology and medical microbiology 2009, 55:115-119.
186. Stothard D.R., Williams J.A., Van Der Pol B., et al. Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid. Infect. Immun. 1998, 66:6010-6013.
187. Su H., Caldwell H.D. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 1995, 63(9):3302-3308.
188. Sun G., Pal S., Weiland J., et al. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine 2009, 27:5020-5025.
189. Szabo S.J., Kim S.T., Costa G.L., et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100(6):655-669.
190. Taylor B.D., Haggerty C.L. Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. Infect. Drug Resist. 2011, 4:19-29.
191. Taylor-Robinson D., Stacey C.M., Jensen J.S., et al. Further observations, mainly serological, on a cohort of women with or without pelvic inflammatory disease. Int. J. STD AIDS. 2009, 20(10):712-718.
192. Thomson N.R., Yeats C., Bell K., et al. The Chlamydophila abortus genome sequence reveals an array of variable proteins that contribute to interspecies variation. Genome Res. 2005, 15(5):629-640. Epub 2005 Apr 18.
193. Thomson N.R., Holden M.T., Carder C., et al. Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res. 2008, 18(1):161-171.
194. Tracy C.R., Steers W.D., Costabile R. Diagnosis and management of epididymitis. Urol. Clin. North Am. 2008, 35:101-108.
195. Trei J.S., Canas L.C., Gould P.L. Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex. Transm. Dis. 2008, 35(9):827-833.
196. Trojian T.H., Lishnak T.S., Heiman D. Epididymitis and Orchitis: An overview. Am. Fam. Physician 2009, 79(7):583-587.
197. van der Laar M.J., van Duynhoven Y.T., Fennema J.S., et al. Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin. Med. 1996, 72:261e5.
198. Vitoratos N., Gregoriou O., Papadias C., et al. Sexually transmitted diseases in women with urethral syndrome. Int. J. Gynaecol. Obstet. 1988, 27(2):177-180.
199. Vonck R.A., Darville T., O'Connell C.M., et al. Chlamydial infection increases gonococcal colonization in a novel murin coinfection model. Infect. Immun. 2011, 79(4):1566-1577.
200. Ward M.E. Chlamydial classification, development and structure. British Medical Bulletin 1983, 39:109-115.
201. Ward H., Rönn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr. Opin. HIV AIDS. 2010, 5(4):305-310.
202. Wang S.P., Eschenbach D.A., Holmes K.K., et al. Chlamydia trachomatis infection in Fitz-Hugh-Curtis syndrome. American Journal of Obstetrics and Gynecology 1980, 138:1034-1038.
203. Wang Y., Kahane S., Cutcliffe L.T., et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 2011, 7(9):e1002258.
204. Weidner W., Schiefer H.G., Krauss H., et al. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 1991, (Suppl. 3):S119-S125.
205. Wetmore, C.M., Manhart, L.E., Lowens, M. et al., (2011). Demographic, Behavioral, and Clinical Characteristics of Men With Nongonococcal Urethritis Differ by Etiology: A Case-Comparison Study. Sex. Transm. Dis. 38 (3), 180-186.
206. WHO Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections - Oveview and Estimates 2004, Accessed October 10, 2011. http://www.who.int/hiv/pub/sti/pub7/en/index.html.
207. WHO 2007. Prevention of Blindness and Deafness. Planning for the global elimination of trachoma (GET). Report of a WHO consultation. Geneva, 25-26 November 1996. Geneva: WHO, 1997 (WHO/PBL/97.60). Accessed October 8, 2011. http://www.who.int/pbd/publications/%20trachoma/en/get_1996.pdf.
208. WHO Initiative for Vaccine Research. Sexually Transmitted Diseases. Chlamydia trachomatis. World Health Organisation. 2011, Available atAccessed September 6, 2011. http://www.who.int/vaccine_research/diseases/soa_std/en/index1.html.
209. White J.A. Manifestations and management of lymphogranuloma venereum. Curr. Opin. Infect. Dis. 2009, 22(1):57-66.
210. Wilson D.P., Timms P., McElwain D.L., et al. Type III secretion, contact-dependent model for the intracellular development of chlamydia. Bull. Math. Biol. 2006, 68(1):161-178.
211. Wira C.R., Fahey J.V., Sentman C.L., et al. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 2005, 206:306-335.
212. Wira C.R., Fahey J.V., Ghosh M., et al. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am. J. Reprod. Immunol. 2010, 63(6):544-565.
213. Wira C.R., Patel M.V., Ghosh M., Mukura L., et al. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am. J. Reprod. Immunol. 2011, 65(3):196-211.
214. Wu X., Lei L., Gong S., et al. The chlamydial periplasmic stress response serine protease cHtrA is secreted into host cell cytosol. BMC Microbiology 2011, 11:87-103.
215. Wyrick P.B. Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis. 2010, 201(Suppl. 2):S88-S95.
216. Yang X.O., Pappu B.P., Nurieva R., et al. T helper17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28(1):29-39.
217. Zdrodowska-Stefanow B., Ostaszewska I., Darewicz B., et al. Role of Chlamydia trachomatis in epididymitis. Part I: direct and serologic diagnosis. Med. Sci. Monit. 2000, 6:1113-1118.